BioSpace News Archive

Drug Development

Patients Who Used Optune More Than 90 Percent of the Time Had the Greatest Chance of Survival in Novocure’s EF-14 Trial

This is a median survival of 24.9 months from randomization and a five-year survival of 29.3 percent.

November 17, 2017

·

8 min read

Deals

Lianluo Smart Limited Announces Sale of Wholly Owned Subsidiary Beijing Dehaier Medical Technology Co., Ltd.

The Company expects the sale price for BDL will be approximately RMB10 million.

November 17, 2017

·

2 min read

Ncardia Announces Completion of 10.5M Euros Investment Round

The round was led by Épimède, a Belgium venture capital firm.

November 17, 2017

·

2 min read

MiMedx Market Leadership Well Positioned in Light of FDA New Guidance Document

In the final HCT/P Guidance document, FDA updated and clarified its previous draft Guidance documents regarding HCT/Ps.

November 17, 2017

·

9 min read

BioMidwest

Indiana University School of Medicine Researchers Identify First Brain Training Exercise Positively Linked to Dementia Prevention

The cognitive training, called speed of processing, showed benefits up to 10 years after study participants underwent the mental exercise program, said Frederick W. Unverzagt, PhD, professor of psychiatry at Indiana University School of Medicine.

November 17, 2017

·

3 min read

OBN Celebrates Successful Inaugural BioSeed Conference Supporting Innovative Life Sciences Companies’ Accessing Seed Funding

OBN (UK) Ltd, the membership organisation that supports the life sciences industry, is delighted to announce the success of their new event BioSeed which was held on 14th November at EY’s London offices.

November 17, 2017

·

1 min read

Biotech Beach

CytRx Corporation Regains Nasdaq Listing Compliance

Separately, CytRx has engaged the services of a third party firm to conduct an in-depth investigation to determine the extent of short-selling in the Company’s common stock.

November 17, 2017

·

3 min read

Successful First-in-Human Testing of Implandata’s Next Generation EYEMATE Micro-Sensor for Improved Monitoring of Glaucoma Patients

Implandata now reports that its optimized next generation EYEMATE micro-sensor implant for intraocular placement has successfully passed first-in-human validation.

November 17, 2017

·

3 min read

Policy

Statement by FDA Commissioner Scott Gottlieb, M.D., on Efforts to Address Impact of IV Fluid Shortages Following Hurricane Destruction and Resolve Manufacturing Shortfalls

It’s been nine weeks since Hurricane Maria made landfall on Puerto Rico and the island continues to struggle to recover from the devastation brought by this storm, as well as Hurricane Irma.

November 17, 2017

·

5 min read

VBL Therapeutics Prices 2.5 Million Ordinary Share Offering

The offering is subject to customary closing conditions and is expected to close on or about November 21, 2017.

November 17, 2017

·

4 min read